|
Junior Member
|
|
Join Date: Jul 2012
Posts: 77
|
|
|
Junior Member
Join Date: Jul 2012
Posts: 77
|
Thanks for the links.
The Fierce Biotech article (dated ?) calls phase III imminent and says if confirmatory, the drug would be produced starting 2012. But then the Alzheimer's Reading Room link says it never went to phase III , without elaborating. Could it have gone to to Phase III and just not been made public or are there public disclosure requirements that pertain to drug trials?
Last edited by Arsippe; 09-11-2012 at 05:37 AM.
Reason: Incomplete
|